Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Atomic Force Microscopy Differentiates Cancerous from Normal Cells

By LabMedica International staff writers
Posted on 29 Apr 2009
Using an atomic force microscope, scientists discovered that cancer cells and normal cells had different cell surface properties. The difference in the brush layers covering the cell surface might have a biological significance, and could be used for detection of cancer.

Brushes on the cell surface, mostly consisting of microridges and tiny hairs called microvilli, are important for interacting with the external environment. The investigators processed force measurements--taken from the cell surface using an atomic force microscope--according to a model that accounts for these brushes, to quantitatively show that cancerous cells are different. Normal cells have brushes of one length, whereas cancerous cells have mostly two brush lengths of significantly different densities.

The scientific group was led by Igor Sokolov, director of the Nanoengineering and Biotechnology Laboratories Center at Clarkson University (Potsdam, NY, USA). "Cancer cells are traditionally detected by biochemical means," said Professor Sokolov. "However, despite many years of success, those methods have not resulted in defeating cancer. Therefore, it is very important to search for alternative, nontraditional ways of looking at cancer. Investigation of the physical properties of cell surfaces might be one such nontraditional way."

The authors also demonstrated that the difference found in cell surface "brush" is practically impossible to find with other microscopic methods.

The study appeared online in Nature Nanotechnology, on April 13, 2009.

Related Links:

Clarkson University



Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Troponin I Test
Quidel Triage Troponin I Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.